Micrel, Inc. (MCRL) Tops Q1 EPS by 6c; Guides In-line
Get Alerts MCRL Hot Sheet
Join SI Premium – FREE
Micrel, Inc. (NASDAQ: MCRL) reported Q1 EPS of $0.11, $0.06 better than the analyst estimate of $0.05. Revenue for the quarter came in at $61.2 million versus the consensus estimate of $60 million.
Micrel, Inc. sees Q2 2012 EPS of $0.08-$0.11, versus the consensus of $0.09. Micrel, Inc. sees Q2 2012 revenue of (n/a).
For earnings history and earnings-related data on Micrel, Inc. (MCRL) click here.
Micrel, Inc. sees Q2 2012 EPS of $0.08-$0.11, versus the consensus of $0.09. Micrel, Inc. sees Q2 2012 revenue of (n/a).
For earnings history and earnings-related data on Micrel, Inc. (MCRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
- Calamp Corp. (CAMP) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share